(CIDRAP News) – With tougher security requirements set to take effect next April, few state public health laboratories plan to maintain stocks of certain pathogens considered most tempting to bioterrorists, according to the Association of Public Health Laboratories (APHL) and officials with state labs.
(CIDRAP News) – An outbreak of Marburg hemorrhagic fever has grown to 20 cases in western Uganda, and 10 people in two of Uganda's central districts have contracted Ebola hemorrhagic fever, the World Health Organization (WHO) said recently.
Resources & Literature
Recent Literature
Albarino CF, Shoemaker T, Khristova ML, et al. Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012. Virology 2013 Aug 1;442(2):97-100
Blaney JE, Marzi A, Willet M, et al. Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine. PLoS Pathog 2013 May 30;9(5):e1003389
Carroll SA, Towner JS, Sealy TK, et al. Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J Virol 2013 Mar;87(5):2608-16
Gilsdorf A, Morgan D, Leitmeyer K. Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation. BMC Public Health 2012 Nov 21;12:1014
Madrid PB, Chopra S, Manger ID, et al. A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One 2013 Apr 5;8(4):e60579
Pettitt J, Zeitlin L, Kim DH, et al. Therapeutic intervention of Ebola virus infection in Rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med 2013 Aug 21;5(199):199ra113
Sobarzo A, Groseth A, Dolnik O, et al. Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu). J Infect Dis 2013 Jul 15;208(2):299-309
